Y-mAbs Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Revenue	87.69	84.82	65.27	34.9	20.75	Upgrade
Revenue Growth (YoY)	3.38%	29.96%	87.03%	68.18%	-	Upgrade
Cost of Revenue	15.25	11.42	7.57	2.51	2.2	Upgrade
Gross Profit	72.43	73.4	57.7	32.38	18.55	Upgrade
Selling, General & Admin	50.13	44.5	52.47	56.94	45.9	Upgrade
Research & Development	47.41	50.09	88.55	90.88	92.58	Upgrade
Operating Expenses	97.54	94.59	141.02	147.82	138.48	Upgrade
Operating Income	-25.11	-21.19	-83.32	-115.43	-119.94	Upgrade
Interest Expense	-	-	-	-1.85	-	Upgrade
Interest & Investment Income	3.43	4.28	0.64	-	0.02	Upgrade
Currency Exchange Gain (Loss)	-2.04	0.52	-	-	0.58	Upgrade
EBT Excluding Unusual Items	-23.72	-16.38	-82.68	-117.29	-119.34	Upgrade
Merger & Restructuring Charges	-1.52	-4.48	-	-	-	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	62.01	-	Upgrade
Asset Writedown	-	-	-0.62	-	-	Upgrade
Legal Settlements	-3.85	-	-	-	-	Upgrade
Other Unusual Items	-0.72	-	-12.28	-	-	Upgrade
Pretax Income	-29.81	-20.87	-95.57	-55.28	-119.34	Upgrade
Income Tax Expense	-0.15	0.56	-	-	-	Upgrade
Net Income	-29.67	-21.43	-95.57	-55.28	-119.34	Upgrade
Net Income to Common	-29.67	-21.43	-95.57	-55.28	-119.34	Upgrade
Shares Outstanding (Basic)	44	44	44	43	40	Upgrade
Shares Outstanding (Diluted)	44	44	44	43	40	Upgrade
Shares Change (YoY)	1.57%	-0.13%	1.21%	7.64%	14.03%	Upgrade
EPS (Basic)	-0.67	-0.49	-2.19	-1.28	-2.97	Upgrade
EPS (Diluted)	-0.67	-0.49	-2.19	-1.28	-2.97	Upgrade
Free Cash Flow	-15.71	-27.23	-75.92	-103.22	-91.41	Upgrade
Free Cash Flow Per Share	-0.35	-0.62	-1.74	-2.39	-2.28	Upgrade
Gross Margin	82.61%	86.54%	88.41%	92.80%	89.38%	Upgrade
Operating Margin	-28.64%	-24.98%	-127.66%	-330.78%	-578.00%	Upgrade
Profit Margin	-33.83%	-25.26%	-146.43%	-158.40%	-575.12%	Upgrade
Free Cash Flow Margin	-17.92%	-32.11%	-116.32%	-295.79%	-440.51%	Upgrade
EBITDA	-24.58	-20.46	-82.48	-114.65	-119.54	Upgrade
EBITDA Margin	-28.03%	-24.12%	-126.37%	-	-	Upgrade
D&A For EBITDA	0.54	0.74	0.84	0.78	0.4	Upgrade
EBIT	-25.11	-21.19	-83.32	-115.43	-119.94	Upgrade
EBIT Margin	-28.64%	-24.98%	-127.66%	-	-	Upgrade
Revenue as Reported	87.69	84.82	65.27	34.9	20.75	Upgrade

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q